Longitudinal clonal dynamics of HIV-1 latent reservoirs measured by combination quadruplex polymerase chain reaction and sequencing

Proc Natl Acad Sci U S A. 2022 Jan 25;119(4):e2117630119. doi: 10.1073/pnas.2117630119.

Abstract

HIV-1 infection produces a long-lived reservoir of latently infected CD4+ T cells that represents the major barrier to HIV-1 cure. The reservoir contains both intact and defective proviruses, but only the proviruses that are intact can reinitiate infection upon cessation of antiretroviral therapy (ART). Here we combine four-color quantitative PCR and next-generation sequencing (Q4PCR) to distinguish intact and defective proviruses and measure reservoir content longitudinally in 12 infected individuals. Q4PCR differs from other PCR-based methods in that the amplified proviruses are sequence verified as intact or defective. Samples were collected systematically over the course of up to 10 y beginning shortly after the initiation of ART. The size of the defective reservoir was relatively stable with minimal decay during the 10-y observation period. In contrast, the intact proviral reservoir decayed with an estimated half-life of 4.9 y. Nevertheless, both intact and defective proviral reservoirs are dynamic. As a result, the fraction of intact proviruses found in expanded clones of CD4+ T cells increases over time with a concomitant decrease in overall reservoir complexity. Thus, reservoir decay measurements by Q4PCR are quantitatively similar to viral outgrowth assay (VOA) and intact proviral DNA PCR assay (IPDA) with the addition of sequence information that distinguishes intact and defective proviruses and informs reservoir dynamics. The data are consistent with the notion that intact and defective proviruses are under distinct selective pressure, and that the intact proviral reservoir is progressively enriched in expanded clones of CD4+ T cells resulting in diminishing complexity over time.

Keywords: HIV; Q4PCR; latency; reservoir.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Anti-HIV Agents / therapeutic use
  • Anti-Retroviral Agents / therapeutic use
  • Base Sequence / genetics
  • CD4-Positive T-Lymphocytes / virology
  • DNA, Viral / genetics
  • HIV Infections / virology
  • HIV Seropositivity
  • HIV-1 / genetics
  • HIV-1 / metabolism
  • HIV-1 / pathogenicity*
  • Humans
  • Male
  • Middle Aged
  • Polymerase Chain Reaction / methods
  • Proviruses / genetics
  • Sequence Analysis, DNA / methods
  • Viral Load
  • Virus Latency / genetics*
  • Virus Latency / physiology

Substances

  • Anti-HIV Agents
  • Anti-Retroviral Agents
  • DNA, Viral